![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, June 23, 2020 5:52:30 PM
"based upon preliminary development work done for detection of proteins associated with Ebola in 2014',"
" it may not be viewed as worthwhile in a cost:benefit analysis by various agencies or institutions."
As far as I know there is as little known about the Ebola test as there is about the covid test. Is the covid test is based on the same idea? If that is the case the statement, "it may not be viewed as worthwhile", would seem to stem from what was learned during the preliminary development work on Ebola.
Did they not follow up simply because Ebola faded out or it was found to be viewed to be not worthwhile.
I hear the covid test to be released is 100% accurate on the MBs. What has NNLX claimed?
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM